Maria Concetta Fargnoli

17PUBLICATIONS
115CO-AUTHORS
Molecular targetsCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 24, 2026
Prognostic Impact of Concomitant Genomic Alterations in FGFR2-Positive Cholangiocarcinoma Treated With Pemigatinib.

|Nov 26, 2024
Changes in clinical presentation, management, and survival outcomes in patients affected by colorectal cancer following COVID-19 pandemic.

Alessandro Parisi, Riccardo Giampieri, Silvia Villani

|Oct 19, 2024
Efficacy of cisplatin-gemcitabine-durvalumab in patients with advanced biliary tract cancer experiencing early vs late disease relapse after surgery: a large real-life worldwide population.

Federica Lo Prinzi, Francesca Salani, Margherita Rimini

|Jul 24, 2023
Current Evidence and Future Perspectives about the Role of PARP Inhibitors in the Treatment of Thoracic Cancers.

Alessandro Parisi, Francesca Rossi, Chiara De Filippis

|Apr 12, 2023
Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study.

Luca Cantini, Francesco Paoloni, Federica Pecci

|Feb 25, 2023
Ki67 as a Predictor of Response to PARP Inhibitors in Platinum Sensitive BRCA Wild Type Ovarian Cancer: The MITO 37 Retrospective Study.

Valentina Tuninetti, Eleonora Ghisoni, Sandro Pignata

Pageof 3

Frequent Collaborators

4 joint publications

Michele Ghidini

4 joint publications

Alessio Cortellini

3 joint publications

Rossana Berardi

2 joint publications

Michela Roberto